Tuberculosis prevention: current strategies and future directions

A Vasiliu, L Martinez, RK Gupta, Y Hamada… - Clinical Microbiology …, 2023 - Elsevier
Background An estimated one fourth of the world's population is infected with
Mycobacterium tuberculosis, and 5–10% of those infected develop tuberculosis in their …

Recent advances in immunotherapies against infectious diseases

D Ramamurthy, T Nundalall, S Cingo… - Immunotherapy …, 2021 - academic.oup.com
Immunotherapies are disease management strategies that target or manipulate components
of the immune system. Infectious diseases pose a significant threat to human health as …

A review on enzyme complexes of electron transport chain from Mycobacterium tuberculosis as promising drug targets

P Anand, Y Akhter - International journal of biological macromolecules, 2022 - Elsevier
Energy metabolism is a universal process occurring in all life forms. In Mycobacterium
tuberculosis (Mtb), energy production is carried out in two possible ways, oxidative …

A summary on tuberculosis vaccine development—where to go?

F Jiang, T Sun, P Cheng, J Wang, W Gong - Journal of Personalized …, 2023 - mdpi.com
Background: Tuberculosis (TB) is an old infectious disease caused by Mycobacterium
tuberculosis infection. Vaccination is the most effective way to prevent and control TB …

Potential impact of tuberculosis vaccines in China, South Africa, and India

RC Harris, T Sumner, GM Knight, H Zhang… - Science translational …, 2020 - science.org
More effective tuberculosis vaccines are needed to help reach World Health Organization
tuberculosis elimination goals. Insufficient evidence exists on the potential impact of future …

[HTML][HTML] Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis

E Du Bruyn, S Ruzive, CSL Arlehamn, A Sette… - Mucosal …, 2021 - Elsevier
Recent data from mice and non-human primate models of tuberculosis suggested that
CD153, a TNF super family member, plays an important role in Mycobacterium tuberculosis …

[HTML][HTML] In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosis

BT Andongma, Y Huang, F Chen, Q Tang… - Computational and …, 2023 - Elsevier
Tuberculosis (TB) is a global health threat, killing approximately 1.5 million people each
year. The eradication of Mycobacterium tuberculosis, the main causative agent of TB, is …

BCG vaccination strategies against tuberculosis: updates and perspectives

M Qu, X Zhou, H Li - Human Vaccines & Immunotherapeutics, 2021 - Taylor & Francis
ABSTRACT Bacillus Calmette-Guérin (BCG) is the only licensed vaccine against
tuberculosis (TB). However, BCG has variable efficacy and cannot completely prevent TB …

Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India

RC Harris, M Quaife, C Weerasuriya, GB Gomez… - Nature …, 2022 - nature.com
Abstract The M72/AS01E tuberculosis vaccine showed 50%(95% CI: 2–74%) efficacy in a
phase 2B trial in preventing active pulmonary tuberculosis disease, but potential cost …

Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion

H Kim, SJ Shin - Frontiers in Cellular and Infection Microbiology, 2022 - frontiersin.org
Dendritic cells (DCs) are principal defense components that play multifactorial roles in
translating innate immune responses to adaptive immunity in Mycobacterium tuberculosis …